The return of the house call: Providing cancer care in bytes and pieces. (ASCO Connection)
Bipartisan Senate legislation requiring Medicaid to cover costs for routine care of clinical trial participants would “expand access to clinical trials and improve the quality of cancer research,” according to the American Society of Clinical Oncology.
The FDA issued final guidance on labeling for breast implants, aimed at improving communication with patients about potential risks and complications.
The often-overlooked “side effect” of cancer treatment: depression. (CNN)
The Lymphoma Research Foundation announced a $10-million initiative to support clinical research and improve care for follicular lymphoma, which accounts for 20%-30% of all non-Hodgkin’s lymphoma.
The first patient reported to be cured of HIV has died of leukemia. (Fox News)
More evidence that certain dietary factors (folate, magnesium, and dairy products) may help lower the risk of colon cancer. (Gut)
U.S. counties that have chronically high rates of poverty also have more cancer deaths. (American Association for Cancer Research)
A breast cancer survivor talks about a new type of reconstructive surgery that may overcome the numbness and restore feeling to the chest after a mastectomy. (Today)
The American Cancer Society provides some facts about reasons for callbacks after mammography and tries to allay some misconceptions and fears.
Congressional report alleges that Celgene repeatedly raised prices of its blockbuster hematology drug lenalidomide (Revlimid) for no reason other than to boost revenue. (FiercePharma)
The recent death of Supreme Court Justice Ruth Bader Ginsburg provided the backdrop for a review of pancreatic cancer’s poor prognosis. (American Association for Cancer Research)